ArticleClinical parkinsonism & related disorders2026
Factors influencing receipt of specialty neurologic care for patients with Huntington's disease in Colorado.
Article in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Despite recognized importance of specialized neurological care for patients with Huntington's disease (HD), little is known about the number or characteristics of patients who receive this type of care. Objectives: To identify differences between patients receiving care from a movement disorders specialist (MDS) compared to a general neurologist using data from the Colorado All Payers Claims Database between 2019 and 2022. Methods: Logistic regression models were used to compare characteristics of patients who had received care from a MDS compared to a general neurologist in a given year. Results: Approximately half (49.9%) of patients with HD received care from any neurologist and a third (33.8%) received care from a MDS. There were no differences in characteristics between patients who received MDS care compared to general neurologist care. Conclusions: Practice-related characteristics and patient perspectives on care access warrant further study to clarify barriers to specialized neurological care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.